GCG and arthritic joint disease: Metformin, TZDs, DPP-4 inhibitors and GLP-1 analogues may exert an immunomodulatory action downregulating the expression of proinflammatory cytokines and chemokines, thus reducing synovial inflammation and potentially leading to improvement of arthritis.